Quidel announced QuickVue at-home OTC COVID-19 tests to CVS Pharmacy
On Sept. 1, 2021, Quidel announced it will make Quidel’s non-prescription QuickVue® At-Home OTC COVID-19 Test available to…
-
-
SK bioscience and GSK started Phase 3 trial of adjuvanted COVID-19 vaccine candidate
On Aug. 31, 2021, SK bioscience and GlaxoSmithKline announced the initiation of a Phase 3 clinical study of…
-
INOVIO received authorization to conduct phase 3 efficacy trial of COVID-19 DNA vaccine candidate, INO-4800 in Brazil
On Aug. 26, 2021, Inovio Pharma announced that it had received regulatory authorization from Brazil’s ANVISA (Agencia Nacional…
-
Study confirmed virus variants reduce protection against COVID-19
On Aug. 26, 2021, Oregon Health & Science University (OHSU) announced a laboratory study found that blood serum…
-
Pfizer and BioNTech announced collaboration with Brazil’s Eurofarma to manufacture COVID-19 vaccine doses
On Aug. 26, 2021, Pfizer and BioNTech announced the signing of a letter of intent with Eurofarma Laboratorios,…
-
US Department of Defense awarded $14.7 million contract to SteriPack to establish production capability of ExpressCollect collection devices
On Aug. 25, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
-
Johnson & Johnson announced data to support boosting its single-shot COVID-19 vaccine
On Aug. 25, 2021, Johnson & Johnson announced data supporting the use of its COVID-19 vaccine as a…
-
COVID-19 | FDA | Infectious Disease | Vaccine
U.S. FDA approved first COVID-19 vaccine
On Aug. 23, 2021, the U.S. Food and Drug Administration (FDA) approved the first COVID-19 vaccine. The vaccine,…
-
Vaccines still effective against Delta variant of concern, says Oxford-led study of the COVID-19 Infections Survey
On Aug. 19, 2021, the University of Oxford reported that obtaining two vaccine doses remained the most effective…
-
NIH study showed no significant benefit of convalescent plasma for COVID-19 outpatients with early symptoms
On Aug. 18, 2021, the final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO)…
-
NIH scientists developed faster COVID-19 test
On Aug. 16, 2021, scientists at the National Institutes of Health (NIH) announced they had developed a new…
-
Moderna announced supply agreement with Canada for expanded supply of COVID-19 Vaccine from 2022 – 2024
On Aug. 16, 2021, Moderna announced a revised supply agreement with the Government of Canada for up to…
-
Pfizer and BioNTech announced submission of initial data to FDA to support booster dose of COVID-19 vaccine
On Aug. 16, 2021, Pfizer and BioNTech announced that they have submitted Phase 1 data to the U.S….
-
The Department of Veterans Affairs expanded mandate for COVID-19 vaccines among VHA employees
On Aug. 12, 2021, the U.S. Department of Veterans Affairs (VA) announced that it expanded his previous COVID-19…
-
Cardinal Health partnered with Abbott and Quidel to offer rapid OTC COVID-19 tests
On Aug. 10, 2021, Cardinal Health announced its efforts to commercialize and broaden access to over-the-counter rapid COVID-19…
-
Australian Therapeutic Goods Administration granted provisional registration for Moderna’s COVID-19 vaccine
On Aug. 9, 2021, the Therapeutic Goods Administration (TGA), part of the Department of Health, granted provisional approval…
-
CDC reported vaccination offers higher protection than previous COVID-19 infection
On Aug. 6, 2021, the Centers for Disease Control and Prevention (CDC) announced in MMWR that a study…
-
Bio-Techne’s RNAscope aids in tissue diagnosis of COVID-19 in cases with no previous SARS-CoV-2 testing
On Aug. 4, 2021, Bio-Techne announced that scientists at the U.S. Centers for Disease Control and Prevention (CDC)…
-
INOVIO dosed first participant in phase 2 trial for its DNA vaccine against MERS, a Coronavirus Disease
On Aug. 4, 2021, Inovio Pharma announced that the company had dosed the first Phase 2 trial subject…
-
Illumina donated US $1 Million in sequencing capabilities for COVID-19 genomic surveillance in India
On Aug. 3, 2021, Illumina announced it had donated US $1 million in sequencing capabilities to the Molecular…
-
Lilly and Incyte’s baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation
On Aug. 3, 2021, Eli Lilly and Incyte announced results from an additional cohort of 101 adult patients…
-
FDA cleared Vaxart’s IND application for S-only oral tablet COVID-19 vaccine candidate
On Aug. 2, 2021, Vaxart announced that the U.S. Food and Drug Administration has cleared Vaxart’s Investigational New…
-
MPP, WHO, AFRIGEN, BIOVAC, SAMRC and Africa CDC announced LOI for tech transfer hub in South Africa
On Jul. 30, 2021, the Medicines Patent Pool and the World Health Organization, Afrigen Biologics, the Biologicals and…
-
FDA expanded authorized use of REGEN-CO (casirivimab and imdevimab)
On Jul. 30, 2021, Regeneron announced that the U.S. Food and Drug Administration (FDA) had updated the Emergency…
-
Oxford vaccine reached one billion doses released
On Jul. 29, 2021, the University of Oxford’s and AstraZeneca announced that one billion doses of the ChAdOx1…
-
Emergent BioSolutions resumed manufacturing COVID-19 vaccine at Bayview facility
On Jul. 29, 2021, Emergent BioSolutions announced that the U.S. Food and Drug Administration (FDA) had begun allowing…
-
Vaxart reported boosting immune responses in subjects previously vaccinated by a Vaxart vaccine
On Jul. 29, 2021, Vaxart announced that it has shown for the first time in clinical trials that…
-
Cocrystal’s SARS-CoV-2 3CL protease lead CDI-45205 demonstrated broad-spectrum activity against SARS-CoV-2 Delta and Gamma variants
On Jul. 29, 2021, Cocrystal Pharma announced that its SARS-CoV-2 3CL protease lead CDI-45205 and several analogs showed…
-
Oragenics entered into licensing agreement with the NRC of Canada, to pursue next-generation SARS-CoV-2 vaccines
On Jul. 27, 2021, Oragenics announced it has entered into a licensing agreement with the National Research Council…
-
Biotechnology | Cartoons - Original | CDC | COVID-19 | FDA | Infectious Disease | NIH | Non-Profit Research | Vaccine
The COVID-19 Vaccine
The COVID-19 Cartoon illustrates the further politicalization of the U.S. Healthcare System. The choice between getting a vaccine,…
